US Patent Reform Legislation Threatened By Biden Support For Vaccine IP Waiver, Republicans Say
Executive Summary
At hearing on Humira patent thicket, House Republicans express concern that Democrats’ support for transferring US intellectual property rights for COVID-19 vaccines to other countries is a bad sign for collaboration on legislation to reform patent abuses.
You may also be interested in...
From Pricing To Tax Havens: AbbVie On The Hot Seat Again With US Congress
Senate committee seeks details on company’s international tax practices as congress works to implement President Biden’s proposals on corporate tax reform.
Generic Industry’s Future May Include A Role In The Gene Therapy Space
Trade association’s CEO says a new strategic planning initiative will consider among other things how gene therapy could fit into the generic industry business model.
AbbVie’s Stalling Tactics On Humira Pay Off – In More Ways Than One
A US House hearing focused on long-standing criticism of AbbVie for its ability to delay biosimilar competition for Humira. AbbVie was also able to delay the hearing, and that also seemed to work out well for the company.